全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Klára Fekete , Sándor Márton
来源:[J].International Journal of Clinical Pharmacy(IF 0.859), 2017, Vol.39 (2), pp.459-467
摘要:Background Although defined daily doses (DDD) for antiepileptic drugs (AED) have been assigned only in combination therapy, based on the literature, most patients take them in monotherapy. Furthermore, discrepancies between DDD and prescribed daily dose (PDD) were observed. ...
作者:Klára Fekete , Sándor Márton ...
来源:[J].Journal of Stroke and Cerebrovascular Diseases(IF 1.984), 2017, Vol.26 (1), pp.132-138
摘要:Introduction(#br)Recombinant tissue plasminogen activator (rtPA) is an efficient therapy of acute ischemic stroke. The risk of a recurrent ischemic stroke is high. This prospective single center study aimed to assess whether or not the repeated rtPA treatment is beneficial f...
作者:Klára Fekete , Sándor Márton ...
来源:[J].Journal of Stroke and Cerebrovascular Diseases(IF 1.984), 2015, Vol.24 (1), pp.117-124
摘要:Background(#br)This prospective single-center study aimed to identify features determining long-term outcome after thrombolysis in a Central European stroke population.(#br)Methods(#br)Between 1 January, 2004, and 31 December, 2010, 415 patients were treated with recombinant...
作者:Klára Fekete , Sándor Márton
来源:[J].Journal of the Neurological Sciences(IF 2.243), 2016, Vol.369, pp.220-226
摘要:Abstract(#br)Objective(#br)The aim of this study was to determine the outcome of antiepileptic drug (AED) treatment based on seizure freedom, pharmacovigilance reports and effects of concomitant medication on the central nervous system (CNS) of adult epileptic patients registered...
作者:Klára Fekete , Szabolcs Szatmári ...
来源:[J].Journal of Stroke and Cerebrovascular Diseases(IF 1.984), 2014, Vol.23 (1), pp.e31-e37
摘要:Background(#br)Heavy alcohol consumption and smoking are known risk factors for stroke, but their influence on stroke severity and outcome may also be important. We tested if alcohol consumption and smoking relate to initial stroke severity, disability at discharge from hosp...
作者:Klára Fekete , Dóra Sulina ...
来源:[J].Clinical Neurophysiology(IF 3.144), 2019, Vol.130 (7), pp.e49-e49
摘要:Background(#br)We examined whether electroencephalography (EEG) and magnetic evoked potential (MEP) examinations are useful in evaluating the early prognosis in a fatal disease, intracranial haemorrhage (ICH).(#br)Material and methods(#br)Fifty-seven patients were diagnosed with ...
作者:Klára Fekete , Tímea Polyák ...
来源:[J].Clinical Neurophysiology(IF 3.144), 2017, Vol.128 (9), pp.e292-e292
摘要:Objectives(#br)ALS is a progressive neurodegenerative disease. Our aim was to examine the correlation of the severity of symptoms and the findings of electromyography (EMG), electroneurography (ENG) and to find parameters in estimating prognosis.(#br)Methods(#br)EMG/ENG find...
作者:Róbert Rostás , Klára Fekete , István Fekete
来源:[J].Clinical Neurophysiology(IF 3.144), 2019, Vol.130 (7), pp.e89-e89
摘要:Background(#br)ALS is an incurable disease, but with the treatment of the symptoms, better quality of life could be achieved. So early diagnosis is important, especially in the case of bulbar sympto Blink reflex examination is a reliable measure of the microstructural brains...
作者:Klára Fekete , Florian Stögbauer ...
来源:[J].The American Journal of Human Genetics(IF 11.202), 2009, Vol.86 (1), pp.83-87
摘要:Autosomal-dominant striatal degeneration (ADSD) is an autosomal-dominant movement disorder affecting the striatal part of the basal ganglia. ADSD is characterized by bradykinesia, dysarthria, and muscle rigidity. These symptoms resemble idiopathic Parkinson disease, but trem...
作者:Klára Fekete , David Di Cesar ...
来源:[J].Stroke: Journal of the American Heart Association(IF 6.158), 2003, Vol.34 (7), pp.1730-1735
摘要:BACKGROUND AND PURPOSE—: Mannitol is used worldwide to treat acute stroke, although its efficacy and safety have not been proven by randomized trials. METHODS—: In a tricenter, prospective study, we analyzed the 30-day and 1-year case fatality with respect to mannitol treatm...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×